Author: Brian

Investigator uses ICTS resources for COVID-19 research and clinical trial efforts

Rachel Presti, MD, PhD

The CTSA program was developed to accelerate new treatments from the lab to patients, enabled to a large extent by patients participating in and benefiting from clinical trials. Clinical trials provide that needed bridge from human subjects to hypotheses to treatments that can directly benefit human health. And, never has this connection been more critical […]

Measuring the impact of science; How CTSAs use the Translational Science Benefits Model to show real world benefits

Challenge of measuring impact Government, non-profits, and organizations fund research with the ultimate goal of improving health and society. Yet measuring these long-term outcomes can be challenging, and research impact has traditionally been tied to quantitative productivity, like bibliometrics and grant funding, and not necessarily the broader impacts of research. For years, researchers lacked a […]

If you build it, will they come? Linking researcher engagement and scientific productivity in large infrastructure grants

As it turns out, they will. A team of researchers that has been evaluating the Washington University Institute for Clinical and Translational Sciences (ICTS) since 2010 has released new findings. They suggest that CTSA member researchers who engaged with dedicated ICTS infrastructure and resources increased their research productivity; members who took advantage of ICTS services […]